Gastrointestinal Diseases  >>  epirubicin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

12 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00004934: Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Completed
3
US, Canada, Europe, RoW
carboplatin, epirubicin hydrochloride, paclitaxel, conventional surgery
Nordic Society of Gynaecological Oncology - Clinical Trials Unit, European Organisation for Research and Treatment of Cancer - EORTC, NCIC Clinical Trials Group
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
 
05/03
NCT00002615: Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer

Completed
3
500
Europe
cisplatin, epirubicin hydrochloride, fluorouracil, conventional surgery
Medical Research Council
Gastric Cancer
 
12/03
GASTRANOX, NCT00718354: Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT

Completed
3
740
RoW
Enoxaparin, Standard Chemotherapy, Some commonly prescribed Chemotherapy regimens in India are:, - Epirubicin + Cisplatin + Capecitabine, - Capecitabine + Oxaliplatin, - Docetaxil + Carboplatin, - Epirubicin + Cisplatin + Fluorouracil, - Docetaxil + Cisplatin with G/C/S/F support, - Epirubicin + Cisplatin + Flourouracil, - Docetaxil + Cisplatin + Flourouracil
Thrombosis Research Institute
Gastric Cancer, Gastroesophageal Cancer
01/10
08/10
NCT00123318: A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer

Completed
3
52
RoW
epirubicin, Epirubicin Ebewe, Epirubicin Hydrochloride for Injection, cisplatin, Cisplatin Ebewe, Cisplatin Injection, 5-fluorouracil, DBL Fluoruracil Injection BP, Efudix, Radiotherapy, Radiation
Trans Tasman Radiation Oncology Group, The Royal Australian and New Zealand College of Radiologists
Gastric Cancer
02/12
02/12
REAL3, NCT00824785 / 2007-005976-15: Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Checkmark
Apr 2013 - Apr 2013: 
Checkmark Biomarker data
More
Terminated
3
574
Europe
epirubicin, oxaliplatin, capecitabine (EOX), EOX + panitumumab
Royal Marsden NHS Foundation Trust
Oesophago-gastric Cancer
02/13
02/13
NCT01053390: New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

Completed
3
216
RoW
Somatostatin, epirubicin, cisplatin, LV（Leucovorin）、 5-FU（5-Fluorouracil）
Shanghai Jiao Tong University School of Medicine, Xuanwu Hospital, Beijing, Capital Medical University, Peking University First Hospital, Tianjin Medical University Cancer Institute and Hospital, The First Affiliated Hospital of Dalian Medical University, China Medical University, China, The first clinical college of harbin medical university, The Second Affiliated Hospital of Harbin Medical University, Shengjing Hospital, Jilin University, The people's hospital of Heilongjiang province, Eastern Hepatobiliary Surgery Hospital, Shanghai Changzheng Hospital, Shandong Provincial Hospital, Qilu Hospital of Shandong University, Air Force Military Medical University, China, Tang-Du Hospital, Qinghai People's Hospital, Affiliated Hospital of Qinghai University, First Affiliated Hospital of Chongqing Medical University, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, First People's Hospital of Kunming, Lanzhou university second hospital, Xi'an Central Hospital, The first people's hospital of Guiyang, Southwest Hospital, China, The First Affiliated Hospital of Kunming Medical College
Gallbladder Neoplasms
12/13
12/13
NCT02445209: Comparison of Efficacy and Frequency of Adverse Events of 1st Line Palliative Chemotherapy EOX and mDCF Regimens in Advanced HER2-negative Gastric Carcinoma

Completed
3
56
Europe
EOX, mDCF
Jagiellonian University
HER2 Negative Gastric Cancer
02/14
02/14
NCT01327521: Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma

Withdrawn
3
0
US
CyberKnife, CK, TACE, Transcatheter arterial chemoembolization, CT Contrast, contrast dye, doxorubicin, Adriamycin, hydroxydaunorubicin, Epirubicin, Ellence, Pharmorubicin, Epirubicin Ebewe, 5-fluorouracil, 5-FU, f5U, Adrucil, Carac, Efudix, Efudex, Fluoroplex, Mitomycin C, Mutamycin, MTC, Gemcitabine, Gemzar, Cisplatin, cisplatinum, cis-diamminedichloroplatinum(II), CDDP, Platinol, Platinol-AQ, SMANCS, styrene maleic acid neocarzinostatin, poppyseed oil
Albert Koong, Accuray Incorporated
Carcinoma, Hepatocellular
02/14
 
RILOMET-1, NCT01697072 / 2011-004923-11: First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Terminated
3
609
US, Canada, Europe, RoW
Rilotumumab, AMG102, Placebo, sterile protein-free solution, Epirubicin, Ellence, Pharmorubicin PFS, Pharmorubicin RDF, Cisplatin, Platinol, Platinol-AQ, Capecitabine, Xeloda
Amgen
Gastric Cancer
11/14
08/15
CRITICS, NCT00407186 / 2006-004130-32: Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer

Active, not recruiting
3
788
Europe
cisplatin+capecitabine, radiotherapy, epirubicin+cisplatin+capecitabine
Dutch Colorectal Cancer Group, The Netherlands Cancer Institute, Roche Pharma AG
Gastric Cancer
12/18
12/25
QUINTETT, NCT00907543: Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial

Completed
3
96
Canada
Preoperative treatment of chemotherapy and radiation, Postoperative treatment of chemotherapy and radiation
Richard Malthaner
Esophageal Neoplasms
12/18
12/18
PACT-7, NCT00960284: Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer

Completed
2/3
102
Europe
capecitabine, XELODA, cisplatin, Cisplatino-TEVA, epirubicin hydrochloride, Farmarubicina, fluorouracil, FLuorouracile-TEVA, gemcitabine hydrochloride, Gemzar
IRCCS San Raffaele
Pancreatic Cancer
06/09
06/09

Download Options